Vascular

Early results of the Valiant thoracoabdominal aortic aneurysm stent graft shows high technical success and low mortality.

Patrick Kelly, M.D., with Sanford Vascular Innovations, a division of Sanford Health, will collaborate with Boston Scientific, a global medical technology leader, to develop a device that could transform treatment for life-threatening blood clots in the lungs, known as pulmonary embolisms. Dr. Kelly has invented a less-invasive catheter system for treating a pulmonary embolism or […]

Sanford Vascular Innovations (Sanford Health Innovations), a division of Sanford Health working on technology to improve vascular surgery and endovascular care, has been approved by the FDA to study a new device to treat complex aneurysms occurring in the descending aorta. The device, the Unitary Manifold Stent Graft System, was developed by Patrick Kelly, M.D. […]

Dr. Patrick Kelly talks about his upbringing, overcoming dyslexia and his pathway to being a leader in vascular care.

Medtronic plc (NYSE:MDT), a global leader in medical technology, services and solutions and Sanford Health, one of the nation’s largest health care systems, today announced the first patient enrolled in a clinical study using the Medtronic Valiant® TAAA Stent Graft System for minimally invasive repair of thoracoabdominal aortic aneurysm. An aortic aneurysm is a dangerous […]

Sanford Health and the University of South Dakota are collaborating to develop more effective drug-coated balloons to treat peripheral artery disease. The two new devices, which can more precisely deliver drugs to specific arteries, are based on intellectual property jointly created by Sanford’s Patrick Kelly, M.D., and USD’s Gopinath Mani, Ph.D. Drug-coated balloons deliver drugs […]

From blood cancers like leukemia to bleeding and clotting disorders, hundreds of thousands of Americans have issues with their blood.